# Enhanced 3D Brain Tumor Segmentation Using Assorted Precision Training

arXiv: https://arxiv.org/abs/2605.04008 · HTML: https://mlsanity.com/paper/2605.04008/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 7 of its 16 references that are in the map.
- First posted on arXiv 5 May 2026.

## Builds on (most cited first, 7 of 7)

- [SegNet: A Deep Convolutional Encoder-Decoder Architecture for Image Segmentation](https://mlsanity.com/paper/1511.00561/) (2015)
- [Mixed Precision Training](https://mlsanity.com/paper/1710.03740/) (2017)
- [The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation and Radiogenomic Classification](https://mlsanity.com/paper/2107.02314/) (2021)
- [Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge](https://mlsanity.com/paper/1811.02629/) (2018)
- [3D MRI brain tumor segmentation using autoencoder regularization](https://mlsanity.com/paper/1810.11654/) (2018)
- [A survey of loss functions for semantic segmentation](https://mlsanity.com/paper/2006.14822/) (2020)
- [A Two-Stage Cascade Model with Variational Autoencoders and Attention Gates for MRI Brain Tumor Segmentation](https://mlsanity.com/paper/2011.02881/) (2020)

## Abstract (arXiv)

A brain tumor is a medical disorder faced by individuals of all demographics. Medically, it is described as the spread of non-essential cells close to or throughout the brain. Symptoms of this ailment include headaches, seizures, and sensory changes. This research explores two main categories of brain tumors: benign and malignant. Benign spreads steadily, and malignant expresses growth, making it dangerous. Early identification of brain tumors is a crucial factor for the survival of patients. This research provides a state-of-the-art approach to the early identification of tumors within the brain. We implemented the SegResNet architecture, a widely adopted architecture for three-dimensional segmentation, and trained it using the automatic multi-precision method. We incorporated the dice loss function and dice metric for evaluating the model. We got a dice score of 0.84. For the tumor core, we got a dice score of 0.84; for the whole tumor, 0.90; and for the enhanced tumor, we got a score of 0.79.